D-0020-2023 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- November 2, 2022
- Initiation Date
- September 30, 2022
- Termination Date
- September 18, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,520 units
Product Description
Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe)
Reason for Recall
Subpotent Drug: Out of specification for assay
Distribution Pattern
Nationwide in the USA
Code Information
Lot # CFN200020, EXP Nov. 2022